比较病毒宏基因组提取方法。

Comparing Viral Metagenomic Extraction Methods.

机构信息

Centre for Biological Threats and Special Pathogens 1, Robert Koch Institute, Berlin, Germany.

Junior Research Group 4: Bioinformatics, Robert Koch Institute, Berlin, Germany.

出版信息

Curr Issues Mol Biol. 2017;24:59-70. doi: 10.21775/cimb.024.059. Epub 2017 Jul 6.

Abstract

A crucial step in the molecular detection of viruses in clinical specimens is the efficient extraction of viral nucleic acids. The total yield of viral nucleic acid from a clinical specimen is dependent on the specimen's volume, the initial virus concentration and the effectiveness provided by the extraction method. Recent Next Generation Sequencing (NGS)-based diagnostic approaches (i.e. metagenomics) provide a molecular 'open view' into the sample, as they theoretically generate sequence reads of any nucleic acid present in a specimen in a statistically representative manner. However, since a higher virus-related read output promises better sensitivity in the subsequent bioinformatic analysis, the extraction method selected determines the reliability of diagnostic NGS. In this study nine commercially available kits for nucleic acid extraction were compared regarding the simultaneous isolation of DNA and RNA by real-time PCR,four of which were selected for subsequent comparison by NGS (QIAamp Viral RNA Mini Kit, QIAamp DNA Blood Mini Kit, QIAamp cador Pathogen Mini Kit and QIAamp MinElute Virus Spin Kit). The nucleic acid yields and the sequence read output were compared for four different model viruses comprising Reovirus, Orthomyxovirus, Orthopoxvirus and Paramyxovirus, each at defined but varying concentrations in the same sample. The total amount of nucleic acid was processed to sequence the RNA (as cDNA) and the DNA with quantification by Qubit and virus-specific quantitative real-time PCRs. NGS libraries were prepared for sequencing on the Illumina HiSeq 1500 system. Finally, the percentage of reads assignable to each virus was determined via mapping. Evaluation of different commercial nucleic acid extraction kits with four different viruses indicates little variation in the read numbers obtained for transcribed RNA or DNA by NGS. Since NGSis increasingly being used as a tool in diagnostics of infectious diseases, the individual steps of the complete process have to be validated carefully. Here we could show that for virus identification in liquid clinical specimens, any nucleic acid extraction kit that is performing well for PCR diagnostics can be used for NGS diagnostics as well and that the selection of the kit has only a minor impact on the yield of viral reads.

摘要

在临床标本中进行病毒的分子检测,关键步骤是有效地提取病毒核酸。从临床标本中提取病毒核酸的总产率取决于标本的体积、初始病毒浓度和提取方法的有效性。最近基于下一代测序(NGS)的诊断方法(即宏基因组学)为样本提供了分子“全景”,因为它们理论上以统计上有代表性的方式生成样本中任何核酸的序列读取。然而,由于更高的病毒相关读取输出可提高后续生物信息学分析的灵敏度,因此选择的提取方法决定了诊断 NGS 的可靠性。在这项研究中,比较了九种市售的核酸提取试剂盒,这些试剂盒通过实时 PCR 同时分离 DNA 和 RNA,其中四种试剂盒被选为随后的 NGS 比较(QIAGEN Viral RNA Mini Kit、QIAGEN DNA Blood Mini Kit、QIAGEN cador Pathogen Mini Kit 和 QIAamp MinElute Virus Spin Kit)。比较了四种不同模式病毒(包括呼肠孤病毒、正粘病毒、正痘病毒和副粘病毒)的核酸产量和序列读取输出,每种病毒在同一样本中的浓度不同。将核酸总量加工成 RNA(作为 cDNA)和 DNA,并用 Qubit 和病毒特异性定量实时 PCR 进行定量。为在 Illumina HiSeq 1500 系统上测序制备 NGS 文库。最后,通过映射确定每个病毒的可读百分比。使用四种不同病毒评估不同的商业核酸提取试剂盒表明,通过 NGS 获得的转录 RNA 或 DNA 的读取数量变化不大。由于 NGS 越来越多地被用作传染病诊断的工具,因此必须仔细验证完整过程的各个步骤。在这里,我们可以证明,对于液体临床标本中的病毒鉴定,任何在 PCR 诊断中性能良好的核酸提取试剂盒都可用于 NGS 诊断,并且试剂盒的选择对病毒读取的产量影响很小。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索